Fig. 1 · Structure
Documents & Downloads
Fulimetibant
Bradykinin Receptor Antagonist
Fulimetibant is a selective antagonist of bradykinin receptors, primarily B1 and B2 subtypes. This compound inhibits the action of bradykinin, a peptide involved in pain and inflammatory responses. Fulimetibant is utilized in research to investigate the role of bradykinin in various pathological conditions, including pain mechanisms and inflammation-related disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 2231142-90-6 |
| Applications | Bradykinin Receptor Antagonist |
| Formula | C25H21F4N3O3 |
| Molecular Weight | 487.45 |
| SMILES | O=C(C1=C(C2=CN(C3CCC3)N=C2)C=CC(NC(C4(CC4)C5=CC=C(C(F)(F)F)C=C5F)=O)=C1)O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.